A pharmaceutical manufacturer recalled thousands of vials of its COVID-19 antiviral drug remdesivir after an internal investigation found they were contaminated with glass particles. Gilead ...

As the world waits for COVID-19 vaccines, some pharmaceutical companies stand armed and ready with an exciting improvement: better vials to hold the doses. Vials haven’t changed much in the last ...

Drinks including water, soda, beer and wine sold in glass bottles contain more microplastics than those in plastic bottles, ...

In a rush to develop drugs and vaccines in the past ... manufacturing and supplies of specialized materials like glass vials, according to a senior administration official. The federal government ...

The recall comes after the discovery of glass particles in vials of the medication, raising concerns about patient safety at a time when the drug's importance in treating severe COVID-19 cases is ...

Governments and drug companies around the world are placing ... worldwide demand will rise by 1 billion to 2 billion new glass vials, each capable of holding multiple vaccine doses, over the ...

Nipro PharmaPackaging, a provider of glass tubing, glass primary packaging, and medical devices, has launched its Direct-to-Fill (D2F) glass vials. These vials incorporate Stevanato Group's ...

Eli Lilly will begin offering its popular new weight-loss drug Zepbound in vials—in addition to standard injection-pen devices—at about half the price of the original for certain doses.

Amidst a resurgence of COVID-19 cases across the United States, pharmaceutical company Gilead Sciences, Inc. has announced a voluntary recall of its antiviral drug Veklury, commonly known as ...